Found 39 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
PHASE3This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Location
Henan Cancer Hospital
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
NAThis is a randomized noninferiority multicenter trial. Patients will be str...
Status
Active Not Recruiting
Location
National Cancer Center
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
PHASE3The purpose of this study is to evaluate the safety, feasibility and outcom...
Location
N.N. Blokhin National Medical Research Center of Oncology
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
PHASE3The purpose of this study is to evaluate the efficacy and safety of pembrol...
Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Infiltration Pattern of Locally Advanced ESCC
N/AProspectively collect the pathological records of ESCC patients, and analys...
Status
Enrolling By Invitation
Location
Shanghai Chest Hospital
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
NAApplication of the perioperative enhanced recovery protocol has allowed to ...
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University
Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma
PHASE2Esophageal cancer (EC) ranks among the leading malignant gastrointestinal t...
Location
Cancer Hospital, Shantou University Medical College
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
PHASE3The primary objective is to compare docetaxel plus cisplatin (DP) versus vi...
Location
Sun Yat-sen University Cancer Center